Synageva BioPharma Corp $78.90

down -0.48


17/4/2014 08:10 PM  |  NASDAQ : GEVA  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get GEVA Trend Analysis - it has outperformed the S&P 500 by 32%

Partner Headlines

  1. UPDATE: Morgan Stanley Reiterates on Synageva BioPharma as Brain-Blood ...

    Benzinga
  2. UPDATE: Synageva Biopharma™ Announces 2M Share Proposed Public Offering ...

    Benzinga
  3. Synageva BioPharma Completes Target Enrollment in Phase 3 ARISE Trial

    Benzinga
  4. Benzinga's Top Initiations

    Benzinga
  5. UPDATE: Goldman Sachs initiates on Synageva Following Positive Phase II ...

    Benzinga
  6. UPDATE: Leerink Swann Downgrades Synageva BioPharma Corp. on Lack of NT ...

    Benzinga
  7. UPDATE: Wedbush Downgrades Synageva BioPharma on Valuation

    Benzinga
  8. Benzinga's Volume Movers

    Benzinga
  9. Synageva BioPharma Prices 2.75M Share Offering at $56.63/Share

    Benzinga
  10. Synageva BioPharma Corp (GEVA) SVP, CFO Carsten Boess sells 9,927 Shares

    GuruFocus
  11. UPDATE: Piper Jaffray Reiterates Neutral Rating, Lowers PT on Synageva ...

    Benzinga
  12. Synageva Prices 2.15M Share Public Offering at $47.53/Share

    Benzinga
  13. UPDATE: Piper Jaffray Downgrades Synageva to Neutral on Lack of Near-Term ...

    Benzinga
  14. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells 60,0 ...

    GuruFocus
  15. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells 35,0 ...

    GuruFocus
  16. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells 35,0 ...

    GuruFocus
  17. UPDATE: Wedbush Securities Reiterates Outperform Rating, Raises PT on Synageva ...

    Benzinga
  18. Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA)

    Benzinga
  19. Benzinga's Top Initiations

    Benzinga
  20. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells 70,0 ...

    GuruFocus
  21. Synageva BioPharma Corp (GEVA) President & CEO Sanj K Patel sells 70,0 ...

    GuruFocus
  22. Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)

    Benzinga
  23. Synageva BioPharma Corp. (GEVA) SVP, CFO Carsten Boess sells 6,618 Shares

    GuruFocus
  24. Merck &, Quest Diagnostics Among Stocks Setting 52-Week Highs Thursday

    FoxBusiness
  25. Synageva BioPharma, WesBanco Hit 52-week Highs Wednesday

    FoxBusiness
  26. Synageva BioPharma, Deltek Hit 52-week Highs Tuesday

    FoxBusiness
  27. ASML, Wolverine World Wide Included in Stocks Up on High Volume Tuesday

    FoxBusiness
  28. Synageva BioPharma Announces $80 Million Proposed Public Offering of Common ...

    Benzinga
  29. Four Winning Trades Based on Analyst Calls

    Benzinga
  30. CF Industries Holdings, SBA Communications Corporation Included in Stocks ...

    FoxBusiness
  31. Winning Trades Based on Analyst Ratings for June 25

    Benzinga
  32. Synageva BioPharma Jumps on Canaccord Genuity Initiation

    Benzinga
  33. Quest Software, Pharmacyclics, Other Stocks Hit 52-Week Highs Monday

    FoxBusiness
  34. UPDATE: Canaccord Genuity Initiates Synageva BioPharma at BUy, $60 PT; ...

    Benzinga
  35. Synageva BioPharma Corp. (GEVA) President & CEO Sanj K Patel sells 50, ...

    GuruFocus
  36. Synageva BioPharma Announces Interim Data at 8th Annual Lysosomal Disease ...

    Benzinga
Trading Center